KeyBank National Association’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q1
Sell
-15,792
Closed -$299K 1089
2017
Q4
$299K Sell
15,792
-15,391
-49% -$291K ﹤0.01% 895
2017
Q3
$549K Sell
31,183
-4,954
-14% -$87.2K ﹤0.01% 748
2017
Q2
$1.2M Sell
36,137
-8,387
-19% -$279K 0.01% 526
2017
Q1
$1.43M Sell
44,524
-4,328
-9% -$139K 0.01% 471
2016
Q4
$1.77M Sell
48,852
-11,718
-19% -$425K 0.01% 399
2016
Q3
$2.79M Sell
60,570
-1,285
-2% -$59.1K 0.02% 311
2016
Q2
$3.11M Sell
61,855
-3,885
-6% -$195K 0.02% 281
2016
Q1
$3.52M Sell
65,740
-8,391
-11% -$449K 0.02% 269
2015
Q4
$4.87M Sell
74,131
-2,258
-3% -$148K 0.03% 245
2015
Q3
$4.31M Sell
76,389
-2,131
-3% -$120K 0.03% 267
2015
Q2
$4.64M Sell
78,520
-5,900
-7% -$349K 0.03% 277
2015
Q1
$5.26M Sell
84,420
-2,287
-3% -$142K 0.03% 263
2014
Q4
$4.99M Sell
86,707
-7,089
-8% -$408K 0.03% 267
2014
Q3
$5.04M Sell
93,796
-14,121
-13% -$759K 0.03% 271
2014
Q2
$5.66M Sell
107,917
-13,060
-11% -$685K 0.04% 249
2014
Q1
$6.39M Sell
120,977
-37,917
-24% -$2M 0.05% 237
2013
Q4
$6.37M Sell
158,894
-73,529
-32% -$2.95M 0.04% 236
2013
Q3
$8.78M Sell
232,423
-83,441
-26% -$3.15M 0.06% 203
2013
Q2
$12.4M Buy
+315,864
New +$12.4M 0.05% 397